CAS: 5932-27-4; Ethyl 1H-Pyrazole-3-Carboxylate

相似化合物

870532-76-6 3920-50-1 1621-91-6

上下游产品

CAS号623-47-2 丙炔酸乙酯 | CAS号18107-18-1 (三甲硅烷)重氮甲烷 | CAS号64-17-5 乙醇 | CAS号1621-91-6 吡唑-3-羧酸 | CAS号67751-14-8 4-(二甲基氨基)-2-氧代丁... | CAS号67872-78-0 1H-Pyrazole-3-c... | CAS号67-56-1 甲醇 | CAS号76240-19-2 4-乙氧基-2-氧代-3-丁烯酸乙酯 | CAS号133510-30-2 ethyl 2,4-dioxo... | CAS号33064-36-7 吡唑-3-甲酰胺 | CAS号26275-64-9 1H-吡唑-5-碳酰肼 | CAS号23585-49-1 3-(羟甲基)吡唑 | CAS号1007503-15-2 ethyl1-ethyl-1H... | CAS号1621-91-6 吡唑-3-羧酸 | CAS号881668-91-3 4-fluoropyrazol... | CAS号179692-08-1 4-碘-1H-吡唑-3-羧酸乙酯 | CAS号221300-34-1 1H-Pyrazole-3-c... | CAS号611238-75-6 Ethyl 1-[2-[(2-...

5-Cyano-4,5-Dihydro-1H-Pyrazole-3-Carboxylic Acid Ethyl Ester置于sodium Ethanolate体系中,用 乙醇 作为反应溶剂,化学反应 3.0H,以74%的收率获得产物3-吡唑甲酸乙酯
参考文献:Doyle,Michael P.; Colsman,Mark R.; Dorow,Roberta L.,Journal Of Heterocyclic Chemistry,1983,Vol. 20,P. 943-946
标题:Doyle,Michael P.; Colsman,Mark R.; Dorow,Roberta L.,Journal Of Heterocyclic Chemistry,1983,Vol. 20,P. 943-946

专利信息

专利号:WO-2018109082-A1
优先权日:2016-12-15
标题 :Process and intermediate for the preparation of 1-(4-(2-((1-(3,4- difluorophenyl)-1h-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone
发明人：ALMANSA ROSALES CARMEN; CAAMAÑO MOURE ANA MARÃ?A; ENJO BABÃ?O JUAN
权利人:ESTEVE LABOR DR
摘要:The present invention relates to a process for the preparation of 1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone and salts and solvates thereof and to the use of intermediates in the synthesis of these compounds. Also is provided a new intermediate compound.

专利号:US-7612106-B2
优先权日:2004-12-23
标题 :Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
发明人：BOATMAN P DOUGLAS; SCHRADER THOMAS O; SEMPLE GRAEME; SKINNER PHILIP J; JUNG JAE-KYU
权利人:ARENA PHARM INC
摘要:The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. n nAlso provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of α-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers, DP receptor antagonists, and the like.

专利号:WO-2025008732-A1
优先权日:2023-07-03
标 题 :Novel compounds as modulators of il17
发明人：DESAI RANJIT; DESAI JIGAR
权利人:ZYDUS LIFESCIENCES LTD
摘要:The present invention relates to novel compounds of general formula (1), their suitable pharmaceutically acceptable salts, their solvates, their hydrates, their stereoisomers, their polymorphs, their racemic mixtures, their optically active forms and their use in the treatment of inflammatory conditions such as psoriasis, asthma, psoriatic arthritis or rheumatoid arthritis. Further, the present invention relates to processes of preparing such compounds, novel intermediates involved in their synthesis.

专利号:JP-2007501635-A
优先权日:2003-05-16
标题 :Method for the synthesis of β-lactamase inhibitor intermediates

专利号:JP-2006528978-A
优先权日:2003-05-16
标题:Method for the synthesis of β-lactamase inhibitor intermediates

专利号:CN-108546266-B
优先权日:2018-07-25
标 题:Synthesis method of 1,4,6, 7-tetrahydropyrane [4,3-C ] pyrazole-3-carboxylic acid